Tech Company Financing Transactions
Ziarco Funding Round
BVF Partners and Pfizer Venture Investments joined a Series A funding round for Ziarco. The funding round was announced on 11/6/2012.
Transaction Overview
Company Name
Announced On
11/6/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
BVF Partners (Lead Investor)
Proceeds Purpose
Proceeds from the funding will be invested to advance the research and development of novel therapeutic agents to address inflammatory and allergic diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12-17 Upper Bridge St. 205 - 206
Canterbury Kent, CT1 2NF
UK
Canterbury Kent, CT1 2NF
UK
Phone
Website
Email Address
Overview
Ziarco is an independent, clinical stage biotechnology company progressing novel & differentiated therapies for inflammatory and allergic diseases, using both oral and topical routes of delivery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike Yeadon
Chief Scientific Officer
Wai Liu
VP - Bus. Development
Lynn Purkins
Browse more venture capital transactions:
Prev: 11/6/2012: HubSpot venture capital transaction
Next: 11/6/2012: AFS Technologies venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs